Physician

Jennifer Tanya Suders, D.O.

According to 2025 Medicare claims, Jennifer Suders, D.O. (NPI: 1417205493) practices nephrology in the Wheeling, WV-OH market, with the plurality of this provider's patient population coming from Belmont, OH. This provider's primary affiliated billing organization is NEPHROLOGY ASSOCIATES, INC (NPI: 1457430134; TIN: 550667825) and primary practice location at 26003-6379. Suders is affiliated with the ACO West Virginia (ACO ID: A3563), participating under the MSSP model.

Suders' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 322 traditional Medicare patients, billed 1,032 HCPCS/CPT codes, and received $111,091 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 1,109 prescription claims across 185 beneficiaries totaling $90,060 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 77 claims. Open Payments data shows 5 records totaling $32. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $904 to $90,060. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	254	598	$57,003
2018	479	2,144	$172,880
2019	484	1,660	$147,000
2020	447	1,483	$150,924
2021	374	1,069	$123,247
2022	344	930	$108,229
2023	335	1,045	$118,831
2024	322	1,032	$111,091

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	15	28	$904
2016	N/R	17	$101
2017	85	195	$38,809
2018	247	1,374	$96,698
2019	228	1,320	$88,545
2020	201	1,183	$108,887
2021	174	980	$97,948
2022	192	969	$66,543
2023	185	1,106	$95,477
2024	185	1,109	$90,060

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	51	$6,916
2020	N/R	96	$9,904
2021	N/R	56	$4,566
2022	N/R	88	$11,263
2023	N/R	82	$8,454
2024	N/R	77	$3,393

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	51	114	$265
90961	Dialysis services, 2-3 physician visits per month (20 years or older)	32	52	$221
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	75	85	$132
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	86	316	$90
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	164	232	$87

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	47	1,710	$32,206
Cinacalcet Hcl	Cinacalcet Hcl	13	375	$15,184
Sevelamer Carbonate	Sevelamer Carbonate	14	780	$3,923
Calcitriol	Calcitriol	114	7,057	$1,768
Clonidine	Clonidine	11	308	$866

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	23	$1,438
J7515	Cyclosporine, oral, 25 mg	N	N/R	12	$1,321
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	22	$395
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	20	$238

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$32	Otsuka America Pharmaceutical, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jennifer Tanya Suders, D.O.?

Tedicare shows public-source Medicare data for Jennifer Tanya Suders, D.O. (NPI 1417205493), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jennifer Tanya Suders, D.O. have ACO affiliation data?

Jennifer Tanya Suders, D.O. is shown with ACO affiliation data for ACO West Virginia (MSSP, ACO ID A3563).

What billing organization is linked to Jennifer Tanya Suders, D.O.?

Jennifer Tanya Suders, D.O. is linked to NEPHROLOGY ASSOCIATES, INC (billing NPI 1457430134) in the available physician profile data.

Does Jennifer Tanya Suders, D.O. have Open Payments data?

Jennifer Tanya Suders, D.O. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.